Pfizer’s (NYSE:PFE) Q3 Earnings Results: Revenue In Line With Expectations
Update: 2025-11-04
Description
Pfizer's Q3 2025 earnings report showed mixed results: sales matched expectations but dipped year-over-year, while profits surpassed forecasts. Despite a drop in operating margin, Pfizer remains optimistic about its future, with a revised profit forecast and commitment to investing in new medicines. Investors view this as a mixed quarter, with steady stock price but concerns about sales momentum.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
